Search research articles
Contact Us
Filters
Showing results (51-60 of 83) with videos related to
Page
of 9
Sort By:
Anticancer Research
|
September 1, 1989
Molecular basis of cisplatin resistance in human carcinomas: model systems and patients
K J Scanlon, M Kashani-Sabet, H Miyachi, et al.
Biochemical Pharmacology
|
February 1, 1988
Mechanisms of cross-resistance to methotrexate and 5-fluorouracil in an A2780 human ovarian carcinoma cell subline resistant to cisplatin
E M Newman, Y Lu, M Kashani-Sabet, et al.
Cancer Letters
|
January 1, 1986
Effects of methotrexate on folates in Krebs ascites and L1210 murine leukemia cells
V Kesavan, P Sur, M T Doig, et al.
In Vivo (Athens, Greece)
|
May 1, 1990
Evaluation of N-4-(hydroxycarbophenyl) retinamide as a cancer prevention agent and as a cancer chemotherapeutic agent
J Han, L Jiao, Y Lu, et al.
Advances in Enzyme Regulation
|
January 1, 1992
The utility of an anti-fos ribozyme in reversing cisplatin resistance in human carcinomas
T Funato, E Yoshida, L Jiao, et al.
Biochemical Pharmacology
|
October 7, 1994
Suppression of H-ras-mediated transformation in NIH3T3 cells by a ras ribozyme
T Funato, T Shitara, T Tone, et al.
Molecular Pharmacology
|
May 1, 1981
Inhibition of serine metabolism by tetrahydrohomofolate in L1210 mouse leukemia cells
K J Scanlon, A R Cashmore, B A Moroson, et al.
Biochemical Pharmacology
|
July 1, 1985
PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines
M J Yagi, S E Chin, K J Scanlon, et al.
Chemotherapy
|
January 1, 1988
Multiple transport pathways for L1210 cells: uptake of PTT.119, a bifunctional alkylator with carrier amino acids
M J Yagi, K J Scanlon, S E Chin, et al.
Cancer Research
|
September 1, 1983
Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells
K J Scanlon, R L Safirstein, H Thies, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 83) with videos related to
Sort By:
Page
of 9
Anticancer Research
|
September 1, 1989
Molecular basis of cisplatin resistance in human carcinomas: model systems and patients
K J Scanlon, M Kashani-Sabet, H Miyachi, et al.
Biochemical Pharmacology
|
February 1, 1988
Mechanisms of cross-resistance to methotrexate and 5-fluorouracil in an A2780 human ovarian carcinoma cell subline resistant to cisplatin
E M Newman, Y Lu, M Kashani-Sabet, et al.
Cancer Letters
|
January 1, 1986
Effects of methotrexate on folates in Krebs ascites and L1210 murine leukemia cells
V Kesavan, P Sur, M T Doig, et al.
In Vivo (Athens, Greece)
|
May 1, 1990
Evaluation of N-4-(hydroxycarbophenyl) retinamide as a cancer prevention agent and as a cancer chemotherapeutic agent
J Han, L Jiao, Y Lu, et al.
Advances in Enzyme Regulation
|
January 1, 1992
The utility of an anti-fos ribozyme in reversing cisplatin resistance in human carcinomas
T Funato, E Yoshida, L Jiao, et al.
Biochemical Pharmacology
|
October 7, 1994
Suppression of H-ras-mediated transformation in NIH3T3 cells by a ras ribozyme
T Funato, T Shitara, T Tone, et al.
Molecular Pharmacology
|
May 1, 1981
Inhibition of serine metabolism by tetrahydrohomofolate in L1210 mouse leukemia cells
K J Scanlon, A R Cashmore, B A Moroson, et al.
Biochemical Pharmacology
|
July 1, 1985
PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines
M J Yagi, S E Chin, K J Scanlon, et al.
Chemotherapy
|
January 1, 1988
Multiple transport pathways for L1210 cells: uptake of PTT.119, a bifunctional alkylator with carrier amino acids
M J Yagi, K J Scanlon, S E Chin, et al.
Cancer Research
|
September 1, 1983
Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells
K J Scanlon, R L Safirstein, H Thies, et al.
Page
of 9